Recent Posts
- Bladder Cancer Advocacy Network Think Tank
- LUGPA 2024 Annual Meeting
- Bladder Cancer Advocacy Network Patient Summit
- H.C. Wainwright 26th Annual Global Investment Conference
- ImmunityBio Announces Insurance Coverage of ANKTIVA® Across Multiple States with First Commercial Doses Administered Just Weeks After FDA Approval—Opening New Era for Immunotherapy Beyond Checkpoint Inhibitors